Replies to post #245406 on Biotech Values

[DewDiligence]

ABT acquires CSII for $20/sh cash—a 50% premium to today’s closing price:

• Abbott will gain an innovative, complementary solution in treating vascular disease through CSI's leading atherectomy system, which prepares vessels for angioplasty or stenting to restore blood flow

• CSI's offering will support Abbott's ability to provide better care for patients with peripheral and coronary artery disease

The nominal deal value is $890M. Closing requires approval of CSII’s shareholders, but that’s a fait accompli.

The Medical Devices business segment is ABT’s largest, accounting for 37% of corporate sales in 4Q22 (#msg-171028943).

ABT’s 2023 financial guidance remains unchanged—see #msg-171028771 for details.

[chantillylive]

Thank you Dew.
I had RVNC as riskier than ENTA but was at least on the same page as you. Also saw ABT as the Costco or BRK.B of the
five. Fortunately, added to my RVNC position last year in the teens. TU.
Will reenter ENTA but cannot understand PFE's price action.
Thanks again.
cl
BNGO on your watch list?

[vinmantoo]

I_consider_all_five—(RVNC, ENTA, ABT, BMY, PFE)—to_be_buys at their current valuations, but there is a wide disparity in risk and upside potential:

I agree and bought some more RVNC. I have been thinking about buying PFE for a while but haven't pulled the trigger on that yet.

[sab63090]

Thanks, I do have trouble with $PFE (Bourla)...

[DewDiligence]

BMY -2.5% today—possible reason is that the CEO just sold $18M worth of stock—approximately half his holding—(the Form-4 filing hit the wires last night after the close):

https://www.sec.gov/Archives/edgar/data/14272/000001427223000044/xslF345X03/wf-form4_167590496019590.xml

It's hard to interpret a transaction of this size as non-bearish. I wonder if Giovanni Caforio is planning to retire in the next 12-18 months.

[DewDiligence]

ABT TriClip (tricuspid-value clip) highlighted_at ACC…

NYT story (Gina Kolata):
https://www.nytimes.com/2023/03/04/health/tricuspid-valve-clip-leakage.html

ABT’s own PR:
https://finance.yahoo.com/news/data-show-superiority-abbotts-triclip-154100517.html

[DewDiligence]

ABT +7% on 1Q23 results/2023 guidance:

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171723150